Insights on Voting Rights and Share Issuance from Nyxoah

Understanding Nyxoah's Voting Rights and Share Structure
Nyxoah, a prominent name in the healthcare sector, is committed to transparency regarding its share structure and voting rights. This article aims to provide a clear breakdown of the current status of shares and voting rights within the company.
Current Share Capital Overview
As of the latest update, Nyxoah's share capital is noted at EUR 6,432,066.28. This figure represents the total monetary value of shares issued by the company. This capital plays a vital role in determining the financial health of a business and its potential for growth.
Total Voting Rights Issued
The total number of securities carrying voting rights stands at an impressive 37,441,140, all categorized as ordinary shares. This indicates that each share provides its holder with a say in the company's governance, which is essential for maintaining shareholder confidence and engagement.
Significance of Voting Rights
Voting rights empower shareholders to influence key decisions, from electing board members to approving major corporate actions. Such democracy within corporate structures ensures that investors can voice their opinions and contribute to the strategic direction of the company.
Detailed Breakdown of Voting Rights
When it comes to determining the total number of voting rights, Nyxoah confirms that the denominator also remains at 37,441,140. This alignment reassures shareholders that every share carries an equivalent weight in voting privileges, fostering a balanced environment where each shareholder's voice is heard equally.
Subscription Rights Not Issued Yet
An interesting aspect of Nyxoah's capital structure is the number of rights to subscribe to securities that are not yet issued. This figure currently sits at 2,793,941. It's important to note that this statistic represents all granted subscription rights and excludes those that have been issued but not granted. Such insights can indicate potential future dilution of shares if these rights are exercised.
Company Contact Information
For investors and interested parties seeking further details about Nyxoah’s performance and corporate governance, contact John Landry, the Chief Financial Officer (CFO) of Nyxoah. He can be reached via email at IR@nyxoah.com. This direct line to company management underscores Nyxoah's commitment to investor relations and transparency.
Frequently Asked Questions
What is Nyxoah's current share capital?
Nyxoah's current share capital is EUR 6,432,066.28.
How many voting rights does each shareholder hold?
Each ordinary share represents a voting right, with a total of 37,441,140 voting rights currently issued.
What is the total number of shares in Nyxoah?
The total number of securities carrying voting rights amounts to 37,441,140.
How many subscription rights have been granted but not yet issued?
There are currently 2,793,941 rights to subscribe to securities that have not yet been issued.
Who can I contact for more information about Nyxoah?
You may contact John Landry, CFO of Nyxoah, at IR@nyxoah.com for further inquiries.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.